Rosiglitazone for type 2 diabetes mellitus

This publication has 95 references indexed in Scilit:

• Rosiglitazone Induces Decreases in Bone Mass and Strength that Are Reminiscent of Aged Bone
  Endocrinology, 2007
• A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes
  American Heart Journal, 2007
• The case of the misleading funnel plot
  BMJ, 2006
• Thiazolidinedione Use and Bone Loss in Older Diabetic Adults
  Journal of Clinical Endocrinology & Metabolism, 2006
• Comparison of uptitration of gliclazide with the addition of rosiglitazone to gliclazide in patients with type 2 diabetes inadequately controlled on half-maximal doses of a sulphonylurea
  Acta Diabetologica, 2004
• Measuring inconsistency in meta-analyses
  BMJ, 2003
• Quantifying heterogeneity in a meta‐analysis
  Statistics in Medicine, 2002
• Rosiglitazone
  Drugs, 2002
• Performance of an NIDDM Screening Questionnaire Based on Symptoms and Risk Factors
  Diabetes Care, 1997
• A Coefficient of Agreement for Nominal Scales
  Educational and Psychological Measurement, 1960